Albany, NY -- (SBWIRE) -- 05/19/2016 -- A new market research report by Transparency Market Research, titled "Pediatric Vaccines Market - Global Industry Analysis, Size, Share And Forecasts 2012 – 2018," provides a global scenario of the market for pediatric vaccines in terms of both revenue and volume. The competition within this market has been displayed by presenting an extensive explanation of Porter's five forces model. The report also provides a detailed evaluation of the macro-economic indicators, governing factors, and parent market trends coupled with presenting the attractiveness of each of the segments.

Pediatric vaccines are utilized for the immunization of adolescents and children against numerous infectious diseases such as influenza, diphtheria, hepatitis, meningococcal diseases, and pneumococcal diseases, among others. The increasing initiatives by governments globally for spreading awareness about child healthcare and the rising investments in healthcare are amongst the top factors fuelling the growth of the pediatric vaccines market. In addition, a number of upcoming child healthcare programs organized by the WHO and UNICEF will also drive the growth of this market.

Furthermore, the rising birth rate globally and the increasing occurrence of numerous diseases will also augment the growth of the market. Numerous technological developments in recombinant DNA technology will further have a positive impact on the market. On the other hand, the strict regulations on the approval of these vaccines and the low accessibility in remote areas are amongst the prime factors that may restrain the development of this market.

The pediatric vaccine market is segmented on the basis of technology, type of diseases, and product. In terms of product, the market is segmented into pediatric vaccines, CNS drugs, pediatric hormones, allergy and respiratory drugs, and anti-infective drugs. By technology, the report segments the market into dendritic cells vaccines, live attenuated vaccines, synthetic vaccines, toxoid vaccines, inactivated vaccines, conjugate vaccines, recombinant vector vaccines, and subunit vaccines. Amongst these, the segment of attenuated vaccines has exhibited the highest growth. By disease, the pediatric vaccine market is segmented into infectious diseases, cancer, and allergies. Amongst these, the segment of infectious diseases is leading the market.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=429

However, owing to the increasing occurrence of Leukemia in kids, the segment of cancer is poised to exhibit the highest growth rate in the market in the coming years. Infectious diseases are further segmented into polio, MMR, pneumococcal disease, influenza, meningococcal disease, hepatitis, DTP, rotavirus, and varicella.

By geography, the pediatric vaccines market is segmented into Europe, North America, Asia Pacific, and the Rest of the World (RoW). The North America pediatric vaccine market is presently the largest and is trailed by Europe. On the other hand, Asia Pacific is predicted to register the swiftest growth in the forecast horizon.

The players dominant in the market are GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, Janssen, Crucell, Bharat Biotech, Panacea Biotec, Kaketsuken, Zydus Cadila, Baxter, and Nuron, among others.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/